Ad
related to: crispr stock price today
Search results
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 5 days agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 5 days agoIn March 2023, Zug, Switzerland-headquartered CRISPR Therapeutics closed a $330 million licensing...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoVertex is also working on a next-generation triple regimen that proved non-inferior to the existing...
Iridium secures $94 million Space Force contract By Investing.com
Investing.com· 20 hours agoIridium secures $94 million Space Force contract
Biotech faces a reckoning: 'We've lost our luster in cell therapies'
FierceBiotech· 7 days agoThis story is part one in a four-part series about cell therapy created by the Fierce Biotech team....
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoVisiongain has published a new report: Genome Editing Technologies Market Report 2024-2034: Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application ...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 3 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant